SERINC1 Antibody
-
中文名稱：SERINC1兔多克隆抗體
-
貨號：CSB-PA715783
-
規格：￥1100
-
圖片：
-
The image on the left is immunohistochemistry of paraffin-embedded Human prostate cancer tissue using CSB-PA715783(SERINC1 Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: ×200)
-
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：SERINC1
-
別名：1500011D18Rik antibody; AI315070 antibody; AIGP 2 antibody; KIAA1253 antibody; LRRGT00191 antibody; mKIAA1253 antibody; SERC1_HUMAN antibody; SERINC1 antibody; Serine incorporator 1 antibody; TDE1L antibody; TDE2 antibody; TMS 2 antibody; Tms2 antibody; Tumor differentially expressed 1 protein like antibody; Tumor differentially expressed protein 1-like antibody; Tumor differentially expressed protein 2 antibody; UNQ396/PRO732 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Synthetic peptide of Human SERINC1
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
抗體亞型：IgG
-
純化方式：Antigen affinity purification
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
-
產品提供形式：Liquid
-
應用范圍：ELISA,IHC
-
推薦稀釋比：
Application Recommended Dilution ELISA 1:1000-1:2000 IHC 1:25-1:100 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Enhances the incorporation of serine into phosphatidylserine and sphingolipids.
-
亞細胞定位：Endoplasmic reticulum membrane; Multi-pass membrane protein.
-
蛋白家族：TDE1 family
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
